Production (Stage)
Phio Pharmaceuticals Corp.
PHIO
$2.96
$0.5020.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.15M | -7.42M | -8.68M | -9.38M | -10.83M |
| Total Depreciation and Amortization | 35.00K | 78.00K | 125.00K | 171.00K | 184.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 141.00K | 237.00K | 274.00K | 353.00K | 429.00K |
| Change in Net Operating Assets | -138.00K | -1.01M | -782.00K | -1.20M | -536.00K |
| Cash from Operations | -7.11M | -8.11M | -9.06M | -10.05M | -10.75M |
| Capital Expenditure | -1.00K | 0.00 | 0.00 | -5.00K | -5.00K |
| Sale of Property, Plant, and Equipment | 9.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 8.00K | 0.00 | 0.00 | -5.00K | -5.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.00M | 5.05M | 2.40M | 7.45M | 7.45M |
| Repurchase of Common Stock | -6.00K | -6.00K | -5.00K | -5.00K | -37.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | -2.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.00M | 5.04M | 2.40M | 7.45M | 7.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.11M | -3.07M | -6.66M | -2.61M | -3.34M |